Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a global COVID-19 trial
News
EMA confirms skin cancer risk with LEO’s Picato
The agency concluded that the risks of the medicine outweigh its benefits
Government to extend coronavirus testing
Frontline workers now eligible for testing will include the police, the fire service, frontline benefits workers and those working with vulnerable children and adults among others
Nationwide launch for GP-based trial of COVID-19 therapies
Study aiming to enrol 3,000 patients via more than 100 GP surgeries
Researchers look to NHS Digital data in fight against COVID-19
The data is being used by researchers to evaluate the effectiveness of a number of potential treatments
Chi-Med’s surufatinib bags US fast track designations
The drug has a unique dual mechanism of action that could help fulfil an unmet medical need
Boots and LIVI expand provision of remote access to health advice
The companies will trial how patients could remotely access a Boots pharmacist via the LIVI app
New data back long-term use of Novartis’ Aimovig in migraine
The data add to real world and long-term evidence showing efficacy of Aimovig for migraine prevention across the migraine spectrum
Roche gears up to launch new COVID-19 antibodies test
The test could help indicate if a person has gained immunity against the virus and inform treatment decisions
Researchers call for greater focus on mental health and brain research during pandemic
Experts publish a roadmap to help maintain public health during the pandemic
Edinburgh Uni researchers focus on drug repurposing for COVID-19
The STOPCOVID project has already secured £2 million funding from medical research charity LifeArc
Sir Andrew Witty to co-lead WHO COVID-19 vaccine effort
Sir Andrew will take leave from his current role until the end of the year
Aid groups ask UK gov to stop pharma ‘profiteering’ from COVID-19
COVID-19 vaccines developed with UK taxpayers’ money should be produced ‘patent-free’, they argue
Page & Page teams up with 3D LifePrints, Alder Hey on Distancer launch
The Distancer is a simple, handheld device specifically designed for use in the fight against COVID-19
Healx links with CTF to develop neurofibromatosis therapies
Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).
